CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Aethlon Medical, Inc. - AEMD CFD

1.6792
1.18%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.0616
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 1.6992
Open* 1.7092
1-Year Change* 361.57%
Day's Range* 1.6692 - 1.7192
52 wk Range N/A
Average Volume (10 days) N/A
Average Volume (3 months) N/A
Market Cap N/A
P/E Ratio N/A
Shares Outstanding N/A
Revenue N/A
EPS N/A
Dividend (Yield %) N/A
Beta N/A
Next Earnings Date N/A

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 27, 2024 1.6992 0.0100 0.59% 1.6892 1.7192 1.6692
Mar 26, 2024 1.7492 0.0100 0.57% 1.7392 1.7792 1.7092
Mar 25, 2024 1.6592 0.0000 0.00% 1.6592 1.8092 1.6592
Mar 22, 2024 1.6692 0.0500 3.09% 1.6192 1.6692 1.6192
Mar 21, 2024 1.6392 0.0300 1.86% 1.6092 1.6892 1.6092
Mar 20, 2024 1.6292 0.0200 1.24% 1.6092 1.6292 1.6092
Mar 19, 2024 1.6092 -0.0200 -1.23% 1.6292 1.6792 1.6092
Mar 18, 2024 1.6692 0.0200 1.21% 1.6492 1.6992 1.6192
Mar 15, 2024 1.6792 0.0600 3.71% 1.6192 1.6792 1.6192
Mar 14, 2024 1.6192 0.0000 0.00% 1.6192 1.6792 1.6192
Mar 13, 2024 1.6492 0.0300 1.85% 1.6192 1.6892 1.6192
Mar 12, 2024 1.6592 0.0100 0.61% 1.6492 1.6592 1.6292
Mar 11, 2024 1.7192 0.0400 2.38% 1.6792 1.7192 1.6492
Mar 8, 2024 1.6692 0.0200 1.21% 1.6492 1.6792 1.6492
Mar 7, 2024 1.6692 0.0200 1.21% 1.6492 1.6692 1.6492
Mar 6, 2024 1.6992 -0.0200 -1.16% 1.7192 1.7192 1.6992
Mar 5, 2024 1.6792 0.0300 1.82% 1.6492 1.7192 1.6492
Mar 4, 2024 1.6492 -0.0400 -2.37% 1.6892 1.7092 1.6492
Mar 1, 2024 1.6892 0.0900 5.63% 1.5992 1.7192 1.5992
Feb 29, 2024 1.6192 0.0200 1.25% 1.5992 1.7692 1.5992

Aethlon Medical, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total revenue 0.57425 0.29417 0.6591 0.65019 0.22963
Revenue 0.57425 0.29417 0.6591 0.65019 0.22963
Total Operating Expense 12.615 10.715 8.5506 7.02719 6.22864
Selling/General/Admin. Expenses, Total 12.4729 10.715 8.5506 6.58018 6.22864
Unusual Expense (Income) 0.14212 0.44701 0
Operating Income -12.0407 -10.4209 -7.8915 -6.377 -5.99901
Interest Income (Expense), Net Non-Operating 0.01097 -0.05423 -0.22049
Net Income Before Taxes -12.0298 -10.4209 -7.8915 -6.38004 -6.2195
Net Income After Taxes -12.0298 -10.4209 -7.8915 -6.38004 -6.2195
Minority Interest -0.00614 0.00479 0.00479 0.00609 0.02479
Net Income Before Extra. Items -12.0359 -10.4161 -7.88671 -6.37395 -6.19472
Net Income -12.0359 -10.4161 -7.88671 -6.37395 -6.19472
Income Available to Common Excl. Extra. Items -12.0359 -10.4161 -7.88671 -6.37395 -6.19472
Income Available to Common Incl. Extra. Items -12.0359 -10.4161 -7.88671 -6.37395 -6.19472
Diluted Net Income -12.0359 -10.4161 -7.88671 -6.37395 -6.19472
Diluted Weighted Average Shares 2.05374 1.4757 1.20909 0.34148 0.12084
Diluted EPS Excluding Extraordinary Items -5.86048 -7.05842 -6.52286 -18.6654 -51.2649
Diluted Normalized EPS -5.79128 -7.05842 -6.52286 -17.3564 -51.2649
Other, Net 0.05119
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total revenue 0.57425 0 0 0 0.01312
Revenue 0.57425 0 0 0 0.01312
Total Operating Expense 3.05215 2.84975 6.7131 2.90774 3.79881
Selling/General/Admin. Expenses, Total 3.05215 2.84975 6.57098 2.90774 3.79881
Operating Income -2.4779 -2.84975 -6.7131 -2.90774 -3.78569
Net Income Before Taxes -2.46694 -2.84975 -6.7131 -2.90774 -3.7857
Net Income After Taxes -2.46694 -2.84975 -6.7131 -2.90774 -3.7857
Minority Interest -0.00614 0 0 0 0.00062
Net Income Before Extra. Items -2.47308 -2.84975 -6.7131 -2.90774 -3.78508
Net Income -2.47308 -2.84975 -6.7131 -2.90774 -3.78508
Income Available to Common Excl. Extra. Items -2.47308 -2.84975 -6.7131 -2.90774 -3.78508
Income Available to Common Incl. Extra. Items -2.47308 -2.84975 -6.7131 -2.90774 -3.78508
Diluted Net Income -2.47308 -2.84975 -6.7131 -2.90774 -3.78508
Diluted Weighted Average Shares 2.29254 2.29465 2.1344 1.94376 15.3965
Diluted EPS Excluding Extraordinary Items -1.07875 -1.24191 -3.1452 -1.49593 -0.24584
Dividends per Share - Common Stock Primary Issue 0 0 0
Diluted Normalized EPS -1.07875 -1.24191 -3.07861 -1.49593 -0.24584
Unusual Expense (Income) 0 0 0.14212 0
Interest Income (Expense), Net Non-Operating 0.01097
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total Current Assets 15.0906 18.157 10.3517 10.0411 4.03812
Cash and Short Term Investments 14.5329 17.0724 9.86158 9.60478 3.82807
Cash 14.5329 17.0724 9.86158 9.60478 3.82807
Total Receivables, Net 0 0.12797 0.14908 0.20673 0
Accounts Receivable - Trade, Net 0 0.12797 0.14908 0.20673 0
Prepaid Expenses 0.55762 0.95662 0.34108 0.2296 0.21004
Total Assets 17.5089 19.4179 10.6689 10.3877 4.12296
Property/Plant/Equipment, Total - Net 2.29591 1.13794 0.20134 0.27691 0.00602
Property/Plant/Equipment, Total - Gross 3.03012 1.6318 0.62627 0.66246 0.37436
Accumulated Depreciation, Total -0.73421 -0.49386 -0.42493 -0.38555 -0.36834
Intangibles, Net 0.00165 0.0022 0.05695 0.0575 0.06667
Other Long Term Assets, Total 0.12081 0.12081 0.05889 0.01216 0.01216
Total Current Liabilities 1.50509 1.82405 1.37523 1.06772 1.82389
Accounts Payable 0.43289 0.49996 0.33768 0.28504 0.13193
Accrued Expenses 1.0722 0.97954 0.9227 0.57098 0.646
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 0 0.34455 0.11485 0.21171 0.08365
Total Liabilities 2.44473 2.28485 1.23831 0.97814 1.69786
Total Long Term Debt 0 0 0 0 0
Long Term Debt 0
Minority Interest 0 -0.14171 -0.13691 -0.13212 -0.12603
Total Equity 15.0642 17.1331 9.4306 9.40955 2.42511
Common Stock 0.02299 0.01542 0.01215 0.00937 0.019
Additional Paid-In Capital 157.406 147.447 129.332 121.427 108.059
Retained Earnings (Accumulated Deficit) -142.359 -130.329 -119.913 -112.026 -105.652
Total Liabilities & Shareholders’ Equity 17.5089 19.4179 10.6689 10.3877 4.12296
Total Common Shares Outstanding 2.29925 1.54192 1.21506 0.93672 0.1267
Current Port. of LT Debt/Capital Leases 0 0.9623
Other Liabilities, Total 0.93964 0.60251 0 0.04254
Other Equity, Total -0.00614
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 10.4873 13.308 15.0906 18.1723 20.5035
Cash and Short Term Investments 10.1759 12.8977 14.5329 17.4995 19.604
Cash 10.1759 12.8977 14.5329 17.4995 19.604
Total Receivables, Net 0 0 0.11485
Accounts Receivable - Trade, Net 0 0 0.11485
Prepaid Expenses 0.3114 0.41022 0.55762 0.67278 0.78464
Total Assets 12.8283 15.8006 17.5089 20.7245 23.0472
Property/Plant/Equipment, Total - Net 2.21883 2.37031 2.29591 2.42958 2.42095
Intangibles, Net 0.00138 0.00151 0.00165 0.00179 0.00193
Other Long Term Assets, Total 0.12081 0.12081 0.12081 0.12081 0.12081
Total Current Liabilities 1.71053 1.82175 1.50509 2.43602 2.10145
Accounts Payable 0.68494 0.84454 0.43289 0.22679 0.361
Accrued Expenses 1.02559 0.97721 1.0722 1.63499 1.1662
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 0 0.57425 0.57425
Total Liabilities 2.50899 2.69169 2.44473 3.4453 3.17898
Total Long Term Debt 0 0 0 0 0
Minority Interest 0 0 0
Other Liabilities, Total 0.79845 0.86995 0.93964 1.00928 1.07753
Total Equity 10.3193 13.1089 15.0642 17.2792 19.8682
Common Stock 0.00249 0.02484 0.02299 0.02297 0.02295
Additional Paid-In Capital 159.002 158.732 157.406 157.148 156.888
Retained Earnings (Accumulated Deficit) -148.675 -145.641 -142.359 -139.892 -137.042
Total Liabilities & Shareholders’ Equity 12.8283 15.8006 17.5089 20.7245 23.0472
Total Common Shares Outstanding 2.49291 2.48353 2.29925 2.29693 2.29462
Other Equity, Total -0.00957 -0.00714 -0.00614
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -10.4209 -7.8915 -6.38004 -6.2195 -5.69984
Cash From Operating Activities -9.76716 -6.76494 -5.19761 -4.29343 -3.91068
Cash From Operating Activities 0.12369 0.03994 0.02637 0.0307 0.03566
Non-Cash Items 0.78115 0.77693 1.27107 1.4595 2.04716
Changes in Working Capital -0.25111 0.30969 -0.115 0.43588 -0.29366
Cash From Investing Activities -0.34919 -0.05988 -0.15167 0 -0.02482
Capital Expenditures -0.34919 -0.05988 -0.15167 0 -0.02482
Cash From Financing Activities 17.368 7.12834 11.126 1.14744 9.34987
Issuance (Retirement) of Stock, Net 17.368 7.12834 12.1186 1.14744 9.34987
Issuance (Retirement) of Debt, Net 0 -0.99259 0
Net Change in Cash 7.25162 0.30352 5.77671 -3.146 5.41437
Cash Interest Paid 0 0 0.09539
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
Net income/Starting Line -9.56285 -6.71517 -2.90608 -10.4209 -6.63519
Cash From Operating Activities -7.55841 -5.6073 -2.72892 -9.76716 -6.66808
Cash From Operating Activities 0.16135 0.08322 0.03065 0.12369 0.09836
Non-Cash Items 0.95709 0.68073 0.22324 0.78115 0.53195
Changes in Working Capital 0.886 0.34392 -0.07672 -0.25111 -0.66321
Cash From Investing Activities -0.93182 -0.78033 -0.04117 -0.34919 -0.1368
Capital Expenditures -0.93182 -0.78033 -0.04117 -0.34919 -0.1368
Cash From Financing Activities 8.91735 8.91924 0.61944 17.368 17.3786
Issuance (Retirement) of Stock, Net 8.91735 8.91924 0.61944 17.368 17.3786
Net Change in Cash 0.42712 2.53161 -2.15064 7.25162 10.5737

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Aethlon Medical, Inc.

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.
Industry: Advanced Medical Equipment & Technology (NEC)

11555 Sorrento Valley Road, Suite 203
SAN DIEGO
CALIFORNIA 92121
US

Income Statement

  • Annual
  • Quarterly

News

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

Four reasons why Bitcoin is surging to record highs

Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.

10:18, 14 March 2024

China’s National People’s Congress: The markets have again been left wanting more

China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.

08:23, 8 March 2024
Facade on the Federal Reserve Building in Washington DC

Central Banks: which one will cut first?

Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut

13:14, 6 March 2024

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

People also watch

ETH/USD

3,573.47 Price
+1.790% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

XRP/USD

0.64 Price
+2.520% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

US100

18,249.40 Price
-0.200% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 7.0

Gold

2,233.43 Price
+1.740% 1D Chg, %
Long position overnight fee -0.0188%
Short position overnight fee 0.0106%
Overnight fee time 21:00 (UTC)
Spread 0.80

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading